The etiology of cardiac hypertrophy in infants
Abstract This study aimed to describe the variety of etiologies currently identified in infants with cardiac hypertrophy (CH) and investigate whether there is a relation with hyperinsulinism, echocardiographic characteristics and prognosis. This retrospective cohort study included infants born betwe...
Enregistré dans:
Auteurs principaux: | Raymond Stegeman, Nina D. Paauw, Rosalie de Graaf, Rosa L. E. van Loon, Jacqueline U. M. Termote, Johannes M. P. J. Breur |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8a59adf57ea541cf85c61b74b3c51427 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Wild type transthyretin cardiac amiloidozis as a rare and overlooked underlying etiology in a patient with heart failure with preserved ejection fraction and left ventricular hypertrophy
par: Selda Murat, et autres
Publié: (2021) -
Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy
par: Ke-Qiong Deng, et autres
Publié: (2016) -
Cardiac-specific microRNA-125b deficiency induces perinatal death and cardiac hypertrophy
par: Chen-Yun Chen, et autres
Publié: (2021) -
AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation
par: Roselle Gélinas, et autres
Publié: (2018) -
Genetic contributions to the expression of acquired causes of cardiac hypertrophy in non-ischemic sudden cardiac death victims
par: Lauri Holmström, et autres
Publié: (2021)